{"news_desk": "OpEd", "print_page": "25", "section_name": "Opinion", "subsection_name": null, "byline": {"original": "By DIANA FURCHTGOTT-ROTH", "person": [{"rank": 1, "role": "reported", "firstname": "Diana", "organization": "", "lastname": "FURCHTGOTT-ROTH"}]}, "abstract": "Op-Ed article by economist Diana Furchgott-Roth argues new Treasury Dept regulations aimed at limiting corporate inversions are unlikely to benefit United Sates; holds country's high statutory corporate taxes unfairly punish American-based multinationals; suggests solution is lower taxes, not burdensome new rules.", "type_of_material": "Op-Ed", "word_count": "842", "lead_paragraph": "The new Obama administration rules will ultimately discourage companies from investing in the U.S.", "pub_date": "2016-04-08T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Free Pfizer! Why Inversions Are Good for the U.S.", "content_kicker": "Op-Ed Contributor", "print_headline": "Free Pfizer! Why Inversions Help", "kicker": "Op-Ed Contributor"}, "snippet": "The new Obama administration rules will ultimately discourage companies from investing in the U.S.", "multimedia": [{"height": 126, "url": "images/2016/04/07/opinion/08furchtgott/08furchtgott-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2016/04/07/opinion/08furchtgott/08furchtgott-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 454, "url": "images/2016/04/07/opinion/08furchtgott/08furchtgott-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "454", "xlarge": "images/2016/04/07/opinion/08furchtgott/08furchtgott-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2016/04/07/opinion/08furchtgott/08furchtgott-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/04/07/opinion/08furchtgott/08furchtgott-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2016/04/08/opinion/free-pfizer-why-inversions-are-good-for-the-us.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Corporate Taxes", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Treasury Department", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Tax Shelters", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "ALLERGAN INC", "name": "organizations"}, {"rank": "6", "is_major": "N", "value": "Pfizer Inc", "name": "organizations"}, {"rank": "7", "is_major": "N", "value": "Federal Taxes (US)", "name": "subject"}, {"rank": "8", "is_major": "N", "value": "Obama, Barack", "name": "persons"}, {"rank": "9", "is_major": "N", "value": "Internal Revenue Service", "name": "organizations"}], "blog": [], "_id": "5706ce4138f0d80c57594f1e", "source": "The New York Times"}